7-107690236-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM5PP3PP4PM2_Supporting
This summary comes from the ClinGen Evidence Repository: The c.1262A>G variant in SLC26A4 is a missense variant predicted to cause substitution of glutamine by arginine at amino acid 421 (p.Gln421Arg). The highest population minor allele frequency in gnomAD v2.1.1 is 0.003% (3/113084) in the European (non-Finnish) population, which is lower than the ClinGen Hearing Loss VCEP threshold (<0.007%) for PM2_Supporting, meeting this criterion (PM2_Supporting). The computational predictor REVEL gives a score of 0.954, which is above the threshold of 0.7, evidence that correlates with impact to SLC26A4 function (PP3). Another missense variant, c.1262A>C (p.Gln421Pro), at the same codon has been classified as likely pathogenic for autosomal recessive Pendred syndrome (PM5; PMID:17718863, 23918157, 24224479, 28964290). The p.Gln421Arg variant has been reported in five individuals with hearing loss and inner ear abnormalities, which is highly specific for Pendred syndrome (PP4). Two individuals did not have a variant on the second allele identified (PMIDs: 23965030, 14679580). Two individuals were compound heterozygous for the CEVA haplotype, and one individual was compound heterozygous for a variant of uncertain significance, c.284G>A p.Gly95Glu. Phase for these individuals was unknown (0 PM3 points, PMID:36833263). This variant was re-reviewed on 6.27.2023, and PM2 was downgraded to PM2_Supporting following the most recent specification criteria. Because no contradictory evidence was added, this variant was retained at likely pathogenic for autosomal recessive Pendrome syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: PM5, PM2_Supporting, PP3, PP4. (VCEP specifications version 2; 06.21.2023). LINK:https://erepo.genome.network/evrepo/ui/classification/CA4432734/MONDO:0010134/005
Frequency
Consequence
NM_000441.2 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- Pendred syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- athyreosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- thyroid hypoplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000441.2. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC26A4 | MANE Select | c.1262A>G | p.Gln421Arg | missense splice_region | Exon 10 of 21 | ENSP00000494017.1 | O43511-1 | ||
| SLC26A4 | c.1262A>G | p.Gln421Arg | missense splice_region | Exon 9 of 20 | ENSP00000558760.1 | ||||
| SLC26A4 | c.1262A>G | p.Gln421Arg | missense splice_region | Exon 10 of 20 | ENSP00000558759.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152174Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 250686 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000122 AC: 17AN: 1398330Hom.: 0 Cov.: 24 AF XY: 0.0000114 AC XY: 8AN XY: 699612 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74334 show subpopulations
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at